Modulation of matrix adhesive responses of human neuroblastoma cells by neighboring sequences in the fibronectins by unknown
Modulation of Matrix Adhesive Responses of Human Neuroblastoma 
Cells by Neighboring Sequences in the Fibronectins 
Gabriele Mugnai,* Kristine Lewandowska,* Barbara Carnemolla,* Luciano Zardi,* 
and Lloyd A. Culp* 
*  Department of  Molecular Biology  and Microbiology,  Case Western Reserve University,  School  of Medicine, Cleveland, 
Ohio 44106; and ~Cell Biology Laboratory, Instituto Nazionale per la Ricerca sul Cancro, 16132 Genoa, Italy 
Abstract.  Attachment and neurite extension have been 
measured when Platt or La-N1 human neuroblastoma 
cells respond to tissue culture substrata coated with a 
panel of complementary fragments from the individual 
chains of human plasma (pFN) or cellular fibronectins 
(cFN) purified from thermolysin digests. A  ll0-kD 
fragment (riD),  which contains the Arg-Gly-Asp-Ser 
sequence (RGDS)-dependent cell-binding domain but 
no heparin-binding domains and whose sequences are 
shared in common by both the Qt- and 13-subunits of 
pFN, facilitated attachment of cells that approached 
the level observed with either intact pFN or the hepa- 
ran sulfate-binding platelet factor-4 (PF4).  This attach- 
ment on ill0 was resistant to RGDS-containing peptide 
in the medium. Neurite outgrowth was also maximal 
on fll0, and half of these neurites were also resistant 
to soluble RGDS peptide. Treatment of cells with gly- 
cosaminoglycan lyases failed to alter these responses 
on fll0. Therefore, there is a second "cell-binding" do- 
main in the sequences represented by ill0 that is not 
RGDS- or heparan sulfate-dependent and that facili- 
tates stable attachment and some neurite outgrowth; 
this domain appears to be conformation-dependent. 
Comparisons were also made between two larger 
fragments generated from the two subunits of 
pFN-f145 from the ~t-subunit and f155 from the 
13-subunit-both of which contain the RGDS-dependent 
cell-binding domain and the COOH-terminal heparin- 
binding domain but which differ in the former's con- 
taining some IIICS sequence at its COOH terminus 
and the latter's having an additional type III homology 
unit. Heparin-binding fragments (with no RGDS  activ- 
ity) of I29 and f38, derived from f145 or f155 of pFN, 
respectively, and having the same differences in se- 
quence, were also compared with f44+47 having the 
"extra domaina" characteristic of cFN. Attachment on 
fl45  was slightly sensitive to soluble RGDS peptide; 
attachment on fl55 was much more sensitive.  There 
were also differences in the percentage of cells with 
neurites on fl45 vs.  fl55 but neurites on either frag- 
ment were completely sensitive to RGDS peptide. 
Mixing of f29, t38,  or PF4 with ill0 could not recon- 
stitute the activities demonstrated in f145 or fl55, 
demonstrating that covalently linked sequences are 
critical in modulating these responses. However,  mix- 
ing of f44+47 from cFN with ill0 from pFN in- 
creased the sensitivity to RGDS peptide. Attachment 
on f29 was poor, on f44+47 intermediate, and on 138 
or PF4 very good, demonstrating the modulation of 
responses by the additional type III homology unit (in 
t38) and by alternately spliced sequences represented 
in the "extra domain" (in f44+47).  The COOH- 
terminal heparin-binding domain appears to modulate 
RGDS-dependent cell-binding activity as well (by 
comparing fll0 with either fl45 or f155): (a)  better at- 
tachment on ill0; (b) resistance of attachment on fll0 
to RGDS  peptide; (c) higher percentage of cells with 
neurites on fll0 and their resistance to RGDS peptide; 
and (d) increased resistance of attachment on f155 
when cells were treated with heparitanase. These data 
suggest that the responses of human neuroblastoma 
cells are mediated by two different cell-binding do- 
mains, as well as by the heparan sulfate-binding do- 
main. Furthermore, the cell-binding responses can be 
modulated in four different ways: by neighboring se- 
quences found in the IIICS region of pFN or cFN, by 
"extradomaina," by the additional type III homology 
unit in the 13-subunit of pFN, and by the COOH- 
terminal heparan sulfate-binding domain. 
T 
hE mechanisms by which specific neuronal subpopu- 
lations in animals adhere and react to fibronectin-con- 
raining extracellular matrices are being resolved with 
a variety of experimental approaches in tissue culture model 
systems. Chick embryonic retinal neurons adhere and extend 
neurites  on  fibronectin-coated  tissue  culture  substrata  in 
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dorsal root and sympathetic neurons (39),  as well as to neu- 
rons from rat superior cervical ganglia (41). In the case of 
chick sympathetic neurons that also respond effectively to 
laminin-coated substrata, neurite outgrowth is promoted by 
the heparan  sulfate-binding domain of this molecule and 
not by its cell-binding domain (16). In similar experiments, 
chick dorsal root ganglia have been shown to extend neurites 
effectively on substrata coated with the tetravalent heparan 
sulfate-binding protein, platelet factor-4 (PF4) ~ (Chernoff, 
E. A., S.  L. Tobey, and L. A. Culp, unpublished data; 15). 
Cell surface heparan sulfate proteoglycan interacts with a 
170K glycoprotein to mediate some responses of chick neural 
retina cells (13), and heparan sulfate proteogtycan has been 
localized at the basal lamina interface with peripherai neu- 
rons of various sorts in vivo (5,  17). 
Neuroblastoma tumor ceils from rodents or humans share 
a common origin with peripheral neurons from the neural 
crest of the developing embryo and also effective adherence 
and neurite outgrowth on fibronectin-coated substrata (4, 12, 
14, 38, 40). Therefore, these tumor cells because of ease of 
clonal growth and metabolic/biochemical analyses can be 
used as a partial model for the molecular mechanisms of in- 
teraction of neurons with extracellular matrices,  with the 
caveat that these cells have been exposed to some unique se- 
lection pressures during tumor progression. The same ap- 
plies to a peripheral neural tumor, PC12, which also requires 
nerve growth factor for neurite development (2). However, 
the mechanisms of neurite outgrowth of neuroblastoma cells 
on human plasma fibronectin (pFN) have recently been shown 
to have different molecular bases (15, 46).  Human and rat 
neuroblastoma cells adhere and spread in a pseudopodiat- 
like fashion on PF4-coated substrata,  consistent with the 
high concentrations of heparan sulfate proteoglycans in their 
substratum adhesion sites (14, 29, 47a), but fail to extend neu- 
rites on PF4 under the very same conditions that chick dorsal 
root neurons do (46).  In contrast, several cell-binding frag- 
ments  of  pFN  lacking  heparin-binding  activity  display 
neurite-promoting activity with primary peripheral neurons 
from the chick (40), and neuroblastoma cells extend neurites 
on a chymotrypsin-generated 120K cell-binding fragment of 
pFN (46).  The neurite-generating activity of this fragment 
has been shown to depend only on the Arg-Gly-Asp-Ser se- 
quence (RGDS) contained within this fragment (48), a se- 
quence recognized by a  140K glycoprotein complex on the 
surface of many cell types (3, 9,  11,  19, 36, 37). There is a 
different glycoprotein complex (l15K/150K) on the surface of 
some cells which acts as a receptor for the vitronectin mole- 
cule and which also recognizes an RGDS sequence (44). 
Furthermore, testing of neurite outgrowth of neuroblastoma 
cells on substrata coated with intact pFN molecules with 
soluble RGDS peptides has revealed a second "cell-binding" 
activity in the intact pFN, which is completely insensitive to 
inhibition and independent of heparan sulfate binding (48). 
A third mechanism of neurite outgrowth with these cells is 
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mediated by  a  cell  surface  ganglioside (45),  which acts 
cooperatively with an unidentified cell surface protein when 
these ceils adhere to an appropriate ganglioside-binding sub- 
stratum (31). Therefore, these neural crest-derived tumor 
cells have evolved multiple and alternative mechanisms by 
which they adhere and extend differentiated processes on a 
fibronectin-coated matrix. This system becomes particularly 
valuable for studying the molecular bases for this "differenti- 
ation" process and for resolving the multiple binding activi- 
ties in the fibronectins responsible. 
To pursue the latter objective, fragments of human plasma 
or cellular fibronectins (cFN) that have overlapping permu- 
tations of  the known binding domains of these molecules (30, 
40,  49)  were tested.  Chick embryonic peripheral neurons 
were observed to generate neurites effectively on fibronectin 
fragments containing either the  COOH-terminal heparin- 
binding domain or a cell-binding domain (40).  Since both 
pFN and cFN are composed of more than one polypeptide 
generated by alternative splicing mechanisms of a common 
pre-messenger RNA, as discovered in both protein biochem- 
ical analyses (7,  34,  43)  and in gene structure/expression 
studies  (21, 25),  it would be optimal to examine specific 
regions of individual fibronectin polypeptides. This possibil- 
ity became feasible with the scheme developed by Zardi and 
his colleagues (8,  10, 33) for isolating sequences from the 
two different pFN  0t- and 13-subunits, which differ in the 
amounts of the alternately spliced IIICS region of the mole- 
cule (21), and sequences from the alternately spliced "extra 
domain" (EDa) (21) region characteristic of the cellular fi- 
bronectins. In the studies reported here, the adherence and 
neurite outgrowth properties of two human neuroblastoma 
cells have been measured on substrata coated with these vari- 
ous fragments for comparison with the intact fibronectins 
and with heparan sulfate-binding PF4. Sensitivity to inhibi- 
tion with an RGDS-containing peptide and/or with pretreat- 
ment of the  cell  with specific glycosaminoglycan (GAG) 
lyases, in order to test the contribution of a recently discov- 
ered cryptic GAG-binding domain (28), has been used to dis- 
criminate and further characterize the multiple mechanisms 
of adherence and neurite outgrowth on the fibronectins. 
Materials and Methods 
Cell Culture 
Two human neurohlastoma cell lines, Platt (12) and La-NI (46), were grown 
Mycoplasma-free as stock cultures in DME, supplemented with 10% neona- 
tal calf serum, 250 U/ml penicillin, and 250 gg/ml streptomycin sulfate at 
37~  in a  10% COJhumidified air mixture. Both cell lines were from ad- 
vanced tumors whose cells contained a  50-100-fold amplification of the 
N-myc oncogene (48). In select cases, cells were supplemented with highly 
purified gangliosides by established procedures (23,  3t). Briefly,  subcon- 
fluent cultures after 48 h of growth were exposed to 50 p.M purified gan- 
glioside in DME containing 1% neonatal calf serum for 24 h; cells grew 
continuously in this medium and biochemical analyses of the ganglioside 
fractions of cells using thin-layer chromatography methods demonstrated 
the incorporation of the particular ganglioside into the membrane fraction 
(data not shown). 
Binding Proteins  and Their Fragments 
pFN was purified from blood bank plasma by gelatin-Sepharose affinity 
chromatography (18) and stored at  -85~  in CAPS buffer (0.15 M NaCI, 
1.0 mM CaCl2,  10  mM 3-cyclohexylamino-l-propane sulfonic acid;  pH 
11.0). Human PF4 was purified from outdated platelet packs obtained from 
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(26),  was completely free of contamination with pFN, and was stored in 
PBS supplemented with 0.2 M  NaCI at  -85~ 
A variety of purified fragments of human plasma or cellular fibronectins 
(cFN) were generated as described by Zardi and his collaborators (8,  t0, 
28, 33). Fibronectins were treated with thermolysin and then specific frag- 
ments purified by sequential affinity chromatography on columns of gelatin- 
Sepharose or heparin-Sepharose, or supplementally with a column deriva- 
tized with one of a variety of monoclonal antibodies whose epitopes had 
been mapped. The following fragments are used as described more com- 
pletely in references 8 and 10 and in Fig. 1:  llOK fragment (ill0) from pFN 
contains the RGDS-dependent cell-binding domain (9,  11,  19, 37) and an 
RGDS-independent cell-binding activity (48) but no COOH-terminal hep- 
arin-binding domain;  145K fragment (fl45)  from the ct-subunit of pFN 
contains all of the sequence of ill0 plus a region that includes the COOH- 
terminal heparin-binding domain and some IIICS  sequence at its C-ter- 
minus; 155K fragment (fl55) from the 13-subunit of pFN contains all of the 
sequence of fllO plus a larger region containing the COOH-terminal ,hepa- 
rin-binding domain and an additional type III homology unit; 29K fragment 
(129)  from the r  of pFN  contains the COOH-terminal heparin- 
binding domain and some IIICS sequence but no RGDS-dependent or inde- 
pendent cell-binding domains; 38K fragment (t38) from the [I-subunit  of 
pFN  contains the COOH-terminal  heparin-binding domain but  no  cell- 
binding domains and an additional type III homology unit (this fragment 
is derived from cleavage of fl55); a mixture of  44K and 47K fragments from 
cFN(f44+47)  contains the COOH-terminal heparin-binding domain and 
one of the "extra domains" (EDa) attributed to cellular fibronectins, but no 
cell-binding domains (Fig.  1). 
Adhesion Assays 
For all experiments, the stock cultures were rinsed twice with PBS and then 
fed 0.5 mM EGTA in PBS for shaking at 37~  for 30 min (31, 46, 48). The 
detached cells were pelleted by centrifugation, rinsed twice in PBS by re- 
centrifugation, and suspended in adhesion medium (serum-free DME plus 
250  ~g/ml  heat-treated BSA).  Meanwhile,  tissue culture  plastic cluster 
wells (48-well  dishes) or glass coverslips in select cases were coated with 
20 ~g/ml of the proteins being tested in protein-free DME for 1 h at 37~ 
the wells were rinsed twice with PBS containing 1 mM MgCl2 and 1 mM 
CaCl2  and then re-fed with 200  ~1 of adhesion medium. 
To quantitate the attachment of  cells on substrata coated with various pro- 
teins, stock cultures were radiolabeled during 48 h of exponential growth 
in medium containing 0.5 p.Ci/ml of [methyl-3H]thymidine (sp. act.  10-20 
Ci/mmol); these radiolabeling conditions did not inhibit the growth or neu- 
rite extension of cells. Unlabeled medium was added for an additional 24 h 
before subculturing into experimental wells (as described above). Aliquots 
of cells (2  x  104) were inoculated into wells, which were incubated for 1 h 
at 37~  to evaluate  attachment as follows.  The medium was aspirated off 
and the adherent cells rinsed twice with PBS containing divalent cations; 
the cells were then solubilized with 50 p.l (for 96-well plates) of 1% SDS 
in 0.1  N NaOH for 1 h. Radioactive solubilized cells were quantitated by 
scintillation counting with correction for quenching and compared on per- 
cent bases with values of the original cell suspension. 
For phase-contrast microscopy of cell adherence and neurite outgrowth, 
stock cultures were not radiolabeled. In most cases, plastic tissue culture 
cluster wells were used and, where noted, glass coverslips were also used 
with identical results. The cells were allowed to attach and spread over an 
18-h period before glutaraldehyde fixation and photography on a Nikon Dia- 
phot phase-contrast microscope. Photographs of these fields were used to 
quantitate neurite outgrowth as described previously for cell processes that 
were longer than one cell body diameter (12, 31, 46); statistical signifcance 
was determined with a Student's t-test. 
Peptides A and B 
To evaluate the contribution of the RGDS sequence in the fibronectins as 
a cell-binding activity (36)  known to promote attachment and neurite out- 
growth of  these cells (46, 48), two peptides were tested as soluble inhibitors 
of cell responses. Peptide A (Gly-Arg-Gly-Asp-Ser-Pro-Cys)  and peptide B 
as the control (Gly-Arg-Gly-Glu-Ser-Pro)  were synthesized to specifications 
by Peninsula Laboratories (Belmont, CA) and purified by high pressure liq- 
uid chromatography. None of the effects of peptide A reported here could 
be attributed to the COOH-terminal cysteine residue (data not shown). The 
effectiveness of peptide A was further verified by demonstrating complete 
inhibition of  attachment of BALB/c 3T3 cells at concentrations >100 p.g/ml. 
Figure 1. Origin of fragments from the two chains of human plasma 
fibronectins or the multiple chains of cellular fibronectins. Products 
of thermolysin digestion ofpFN are shown with the larger t"145 and 
fl55 chains liberated initially from the a- and 13-subunits,  respec- 
tively. There are two regions of sequence difference in these frag- 
ments: some IIICS-derived amino acids at the COOH terminus of 
fl45 (IIICS) but not in f155, which lacks a IIICS region, and an addi- 
tional type III homology unit (identified with a  +)  at the COOH 
terminus of fl55. Otherwise, these two fragments both contain the 
RGDS-dependent cell-binding domain (Cello and the COOH-ter- 
minal  heparin-binding domain  (Hepn).  (They also may contain a 
second cell-binding domain  [Cell~i]  as explained in the text which 
is RGDS independent, although its location is still undefined; it is 
likely that this domain results from the conformational folding of 
the protein to bring two distant sequences together.) F145 is subse- 
quently  cleaved to  give  rise to  fll0 and  f29,  which separates the 
RGDS-dependent cell-binding domain  from the  COOH-terminal 
heparin-binding  domain  into  the  respective  fragments.  F155  is 
cleaved to give rise to the same fll0 fragment, as well as f38 with 
its additional type III homology unit.  Cellular FNs go through a 
similar  cleavage  sequence  to  give  rise  to  two  sets  of fragments 
(f44+47),  which contain the "extra domain" (EDa)  characteristic 
of  cFNs,  the  Hepll  domain,  and  some  IIICS  sequence  at  the 
COOH  terminus. 
GAG Lyase Treatment of  Cells 
These treatments were as described by Laterra et al.  (27).  Briefly,  EGTA- 
detached cells ([3H]thymidine-radiolabeled to quantitate attachment) were 
rinsed twice in PBS plus divalent cations and treated in suspension with ei- 
ther 0.1  U/ml chondroitinase ABC/1  ￿  106 cells or 0.02  U/ml Flavobac- 
terium heparitanase in PBS supplemented with divalent cations and 2 mg/ml 
BSA for 1 h with constant agitation at 37~  then a second dose of enzyme 
was added for an additional 0.5-1  h. Viability of  cells after the enzyme treat- 
ments was routinely >93%  when compared with untreated control cells. 
Control or enzyme-treated cells were then inoculated into wells containing 
adhesion medium and in some cases peptide A or B. 
Materials 
BSA, EGTA,  heparin, and gelatin were purchased from Sigma Chemical 
Co., St. Louis, MO; Sepharose 4B from Pharmacia Fine Chemicals, Pis- 
caraway, N J; 48-well cluster dishes from Costar, Cambridge, MA; neonatal 
calf serum  from  Biologos,  Naperville,  IL;  [methyl-3H]thymidine from 
Amersham Corp., Arlington Heights, IL; chondroitinase ABC from Miles 
Biochemicals, Elkhart, IN; and glutaraldehyde (50% wt/wt) and technical 
pan films from Eastman Kodak Co., Rochester, NY. Flavobacterium hepari- 
num heparitanase was kindly provided by Dr. Jeremiah Silbert of Boston's 
Veterans Administration Outpatient Clinic. The highly purified ganglioside 
GTlb  was  generously provided by  Fidia  Research Laboratories,  Abano 
Terme, Italy. Dr. Michael Pierschbacher of the La Jolla Cancer Foundation 
kindly provided the I1.5K fragment of human pFN containing the RGDS 
sequence and generated by chymotrypsin/pepsin treatments (35). 
Results 
Purity of  Fibronectin Fragments 
The fragments of human plasma or cellular fibronectins to 
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lar fibronectins were purified and then proteolytically digested with 
thermolysin for affinity  fractionation as described previously (8, I0) 
and in Materials and Methods. 10 Itg of each fragment class were 
applied to a gradient polyacrylamide gel containing SDS and a 
reducing agent for electrophoresis. The gel was then stained with 
Coomassie Blue for evaluation of patterns. Molecular weights are 
provided on the left side. 
be used in these studies after thermolysin digestion and sub- 
sequent multiple affinity chromatographies are shown in Fig. 
1. The purity of these fragments was assessed by PAGE in 
the presence of SDS and a reducing agent (Fig. 2). The two 
high molecular weight fragments (f145 and fl55) could be 
more readily resolved from each other by longer periods of 
electrophoresis and are derived from the r  and i~-subunits 
of human pFN, respectively, as described previously (8,  10, 
33) and differ by the latter's containing an additional type III 
homology unit and the former containing some IIICS  se- 
quence at  its COOH  terminus (five amino acids of IIICS 
[33]) (Fig. 1). These fragments do not include the Arg-Glu- 
Asp-Val (REDV) functional domain recently discovered by 
Humphries et al.  (20).  FII0 contains sequences shared in 
common by both subunits of human pFN around the RGDS- 
dependent  cell-binding  domain  and  lacks  any  detectable 
heparin-binding activity when assayed as a soluble fragment. 
Also shown is a second cell-binding domain in these larger 
fragments that is RGDS-independent (48 and evidence be- 
low) and whose location has not been mapped precisely (its 
location in Fig. 1 is arbitrary). In contrast, f38 and f29 con- 
tain the COOH-terminal heparin-binding domains of the two 
human  pFN  subunits  but  lack  the  RGDS-dependent  and 
-independent cell-binding domains; they also differ with the 
former containing the additional type III homology unit and 
the latter possibly containing some IIICS  sequence at its 
COOH  terminus.  These  sequences  are  also  shared  with 
f44+47 from human cFN, which also contain the so-called 
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Figure 3.  Adsorption of fibronectin fragments to the substratum 
evaluated by ELISA. 96-well tissue culture dishes were coated with 
20 or 50 gg/ml of the indicated fibronectin fragments or with 1, 10, 
20, or 50 txg/ml intact pFN for 1 h as described in Materials and 
Methods. Wells were then rinsed several times with PBS-II and 
postadsorbed with 250 ~tg/ml BSA in attachment medium for an- 
other hour. ELISA was then conducted using an antibody-excess 
amount of goat anti-pFN antiserum as described previously (28), 
followed by rabbit anti-goat  alkaline phosphatase conjugate and 
p-nitrophenyl phosphate solution, with extensive rinsing between 
all steps. Optical density measurements were taken at 405 nm at t h 
and standard errors routinely fell within •  % of the values shown. 
"extra domaina" of the cellular fibronectins (Fig.  1). The pu- 
rity of these fragments is evident from these gel patterns with 
only minor contaminants evident in f44+47. 
The effectiveness of binding of these fragments to the sub- 
stratum was then evaluated quantitatively by enzyme-linked 
inununosorbent  assay  (ELISA)  using  methods  described 
previously (28). As shown in Fig. 3, intact pFN saturates the 
substratum  at a  concentration well below  10  gg/ml using 
polyclonal goat antibody to human pFN; the multiplicity of 
epitopes available  for antibody binding  is  reflected in  the 
higher maximum optical densities for pFN than those ob- 
served with any of the fragments (which reflect only subsets 
of the epitopes available in the whole molecule). Fragments 
fl55, f44+47, f38, and f29 saturate substratum sites below 20 
~tg/ml (i.e., 50 Ixg/ml fails to elicit higher antibody binding 
and reactivity than 20 I~g/ml).  However, ill0 elicits some- 
what more effective antibody binding at 50 lag/ml,  and fl45 
at this concentration doubles the amount of  antibody-reactive 
material. These results demonstrate that, even though fl45 
and f155 are very similar in size and sequence, the extra type 
III homology unit in fl55 leads to much more stable binding 
of this fragment on the substratum at a lower concentration. 
Attachment Activity with Fibronectin Fragments 
Adherence was tested on each fragment for comparison with 
similar data for intact human pFN and for human PF4 (27). 
As shown in Fig. 4 using a concentration of 20 gg/ml for ad- 
sorption of  all proteins, both Platt and La-N1 neuroblastoma 
cells attached poorly to the f29 univalent heparin-binding 
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Figure 4. Attachment of Platt and LaN-l cells on intact human pFN, 
pFN fragments, or PF4. Platt (solid bars) or La-Nl (hatched bars) 
cells were radiolabeled with [3H]thymidine  as described in Mate- 
rials and Methods. They were then detached by EGTA treatment, 
rinsed twice with  PBS,  and  inoculated  into plastic cluster wells 
coated with 20 I.tg/mi intact  human pFN, various pFN fragments 
(f29,  f38, fU0, f145, or f155 as indicated), or PF4.  The cells were 
allowed to adhere for 1 h at 37~  The wells were then rinsed twice 
with PBS containing divalent cations, and the attached cells were 
solubilized for quantitation of adherence as described in Materials 
and Methods.  The values are given as a percentage of the same 
number of radiolabeled cells in the original cell suspension. Bars 
represent standard errors of multiple determinations. La-NI cell at- 
tachments on pFN or PF4 (not shown)  were virtually identical  to 
the values observed for Platt cells (see reference 48). 
fragment of the a-chains of pFN, particularly in contrast to 
their effective adherence to PF4 whose activity is compara- 
ble to intact pFNs (46).  However, both cells attached more 
effectively to 138,  which contains the same heparin-binding 
domain from the I~-chain ofpFN as well as an additional type 
III homology unit of the molecule. When f44+47 was tested, 
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Figure 5. Dose dependence of Platt cell attachment on pFN or its 
fragments. 96-well tissue culture dishes were coated with pFN, f38, 
t110, f145, f155 at concentrations varying from 5 to 40 ~tg/ml for 1 h; 
they were then rinsed twice with PBS-II and postadsorbed with at- 
tachment  medium.  EGTA-detached  and  [3H]thymidine  radiola- 
beled  Platt  cells  were  inoculated  into wells  in  fresh attachment 
medium. After 1 h attachment, attached cells were assayed as de- 
scribed in Materials and Methods.  Standard deviations are calcu- 
lated for quadruplicate samples. 
its activity was intermediate  between  those of f29 and  138 
(data not shown). Attachment to ill0 was most effective with 
either cell  type and  approached  the activity of intact pFN 
while the activities of f145 or f155 were somewhat reduced, 
particularly for the La-N1 cells. These results were evaluated 
by the Student's  t-test and the following comparisons  were 
statistically significant with a P <  0.005 for each specific cell 
(129 vs.  I38;  129 or 138  vs.  PF4;  fll0 vs.  f145  or f155;  and 
f145  or f155  vs.  pFN).  Furthermore,  both Platt and  La-N1 
cells displayed the same relative patterns of attachment.  The 
dose dependence of attachment of Platt cells on these various 
fragments is shown in Fig. 5. The concentration of fragments 
to achieve a  maximal response was "~20 ~tg/ml (compared 
with 3-5 Ixg/ml for intact pFN) with the single exception of 
f145,  consistent  with the  weaker binding  of this  particular 
fragment to the substratum (see Fig. 3). Also, the same data 
were obtained for either tissue culture plastic or glass sub- 
strata. These results indicate that there are differences in the 
attachment efficiency of cells on these fragments and that the 
sequences  represented  in  the  ED~  (e.g.,  by  comparing 
f44+47 with either 129 or 138) and the extra type III homol- 
ogy repeat (e.g., by comparing 138 with 129) of the molecule 
can affect responses mediated by either the COOH-terminal 
heparin-binding  domain or the RGDS-dependent cell-bind- 
ing domain  (by comparing fll0 with  f145  or f155). 
Effects upon Attachment by Medium-containing 
RGDS Peptide 
It has been shown previously that some adhesion responses 
of cells are mediated by the RGDS-containing  cell-binding 
domain of the fibronectin molecule which reacts with a  140K 
glycoprotein integrin complex (3, 9, 11, 19, 36, 37). However, 
these  human  neuroblastoma  cells  (both  Platt  and  La-N1) 
recognize  at  least  two  and  possibly  three  different  "cell- 
binding"  activities  on  human  pFN,  only  one  of which  is 
RGDS-dependent  (31,  46,  48).  Therefore,  it was important 
to assay these various fragments of pFN for the sensitivity 
of attachment of cells to RGDS-containing peptide (i.e., pep- 
tide A) when added in medium at the same time as cell inocu- 
lation. In all cases, the control peptide B (with a Glu substi- 
tution for the critical Asp residue) was without effect in these 
experiments  (data not shown). 
As  shown  in  Fig.  6,  attachment  to  138  was  completely 
resistant to peptide A, which is expected since 138 lacks the 
RGDS-dependent cell-binding domain but does contain the 
heparin-binding domain. Of significance is the resistance of 
attachment  of Platt cells  to peptide  A  on  fll0,  which  does 
contain  the  RGDS  cell-binding  domain  but  no  heparin- 
binding activity when assayed in solution; these same prepa- 
rations  of peptide  A  inhibited  attachment  of BALB/c  3T3 
cells at concentrations between 30 and  100 Ixg/ml. However, 
this fragment (fll0) has been shown to display a cryptic GAG- 
binding domain that becomes expressed when it binds to the 
substratum (28) and this may provide the basis for resistance 
to peptide A (see below for further analysis of this issue). In 
contrast,  f145  demonstrated  some  sensitivity  to  peptide  A 
and f155 was much more sensitive (Fig. 6); these fragments 
do contain the COOH-terminal heparin domain. The insen- 
sitivity on fll0 and the sensitivity on f155 to peptide A  are 
identical for several preparations of the fragments; the same 
applies if fll0 and f155 are purified separately from the origi- 
nal thermolysin digest or if purified f155 is used as the sub- 
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Figure 6. Sensitivity of Platt cell attachment on pFN fragments to 
peptide A. Attachment of radiolabeled cells was measured as de- 
scribed in Materials and Methods and the legend to Fig. 4 in plastic 
wells precoated with human pFN fragments. Different amounts of 
peptide A were added to the attachment medium along with the cell 
suspension.  After a  l-h incubation,  attached cells were washed, 
solubilized, and quantitated by scintillation counting. Percentage of 
attachment was calculated in reference to the original cell suspen- 
sion as described  in Materials and Methods;  standard errors  are 
shown. It should be noted that attachment on pFN was unaffected 
by all concentrations of peptide A used (not shown [48]). 
strate for protease digestion to obtain ill0. Therefore, a con- 
taminant that co-purifies with one of the fragments is not a 
likely contributor to this differential sensitivity to peptide A. 
It would appear that inclusion of the heparin-binding domain 
in either of these fragments increases the dependence of at- 
tachment upon the RGDS cell-binding domain'. Since both 
of these fragments contain the same COOH-terminal hepa- 
rin-binding domain, this differential response to f145 vs. f155 
must be due to differences in sequence provided by the addi- 
tional type III homology unit of f155 or the partial HICS se- 
quences at the COOH terminus of f145. 
These results led to an experiment in which combinations 
of fragments on the substratum were tested for comparison 
with the individual  fragments. As shown in the  Untreated 
columns of Table I, substrata coated with an equal-weight 
combination of ill0 plus f38 (a mixture that represents virtu- 
ally all the peptide sequence in f155) continued to be resistant 
to peptide A while f155 demonstrated significant sensitivity 
to peptide A (by Student's t-test, P < 0.005 for row 7, column 
1 vs. column 2); raising or lowering the concentration of f38 
did not change this  result  (data not  shown).  Also using a 
weight ratio of 3:1 of fl10/f38 which more approximates the 
equivalent molarities of the binding domains  in the intact 
molecule, identical results were observed (not shown). Mix- 
ing of ill0 plus PF4 was also without effect (row 5, columns 
1 and  2  in  Table I).  Therefore,  the  covalently linked  se- 
quences in f155 contained in the additional type III homology 
unit are necessary to demonstrate this effect and mere addi- 
tion of mixtures of fragments cannot reconstitute the effect. 
The same was observed when La-N1 cells were used in the 
same type of experiment. 
In a similar experiment, cells were also pretreated with ei- 
ther  chondroitinase  ABC  or Flavobacterium  heparitanase 
under the same conditions used by Laterra et al. (27) to dem- 
onstrate that cell surface heparan sulfate proteoglycan does 
mediate certain adhesion responses of fibroblasts. This was 
done to test the relative contributions to these responses of 
the well-characterized COOH-terminal heparin-binding do- 
main  and  a  recently  discovered cryptic  GAG-binding do- 
main, which maps close to the RGDS domain (28).  Table I 
illustrates that f38 and PF4 attachment processes are resis- 
tant to chondroitinase ABC but highly sensitive to hepari- 
tanase  (by  Student's  t-test,  P  <  0.0005  for  rows  1  or  2, 
columns  1 vs.  5),  responses that are expected from these 
heparan sulfate-binding proteins. These results also demon- 
strate the effectiveness of enzymatic removal of cell surface 
heparan sulfates as shown previously (27).  However, under 
the  same treatment conditions,  attachment to ill0 remains 
resistant to either enzyme treatment (row 3,  columns  1,  3, 
and 5) and to peptide A after the enzyme treatment (row 3, 
columns 2, 4, and 6). Therefore, the resistance of attachment 
to fll0 cannot be due to the cryptic GAG-binding domain in 
this  fragment  but  must  be  attributed  to  a  second  "cell- 
binding" activity in the molecule located in these sequences 
(Fig.  1) or to much greater affinity of the RGDS sequence 
to  its cell  surface receptor.  The same applies to  substrata 
coated with a mixture of fll0 plus f38 (row 4). In contrast, 
Table L Effects of Enzyme Pretreatment upon Peptide a Sensitivity of  Attachment on Fragments* 
Fragment 
Untreated  Chondroitinase  ABC  Heparitanase 
-Pep A  +PepA  -Pep A  +Pep A  -Pep A  +Pep A 
1  2  3  4  5  6 
1  PF4  65.6  +  3.1  ND  61.8  +  2.2  ND  14.0  +  1.0  ND 
2  f38  55.7  +  3.3  ND  56.7  +  4.0  ND  16.6  +  1.8  ND 
3  fll0  62.8  +  5.1  63.3  5:2.9  59.1  5:2.3  62.3  5:1.6  55.0  5:2.2  59.5  +  1.4 
4  fl10+f38  63,1  5:  2.2  63.2  5:  1.8  61.3  5:  2.1  64.6  5:  2.0  56.8  5:  2.2  53.9  5:  2.0 
5  fll0+PF4  62.6  +  3.5  69.8  5:  2.8  61.8  5:  1.3  57.3  5:  2.5  33.0  5:  1.8  28.8  5:  3.7 
6  f145  58.0  +  3.0  58.1  5:  4.6  51.9  5:  3.8  56.8  5:  2.4  42.4  5:  2.3  45.9  5:  4.2 
7  f155  52.6  5:4.8  29.8  5:2.6  37.6  5:1.3  38.8  +  2.4  38.9  5:1.1  40.4  5:2.6 
* EGTA-detached and [3H]thymidine-radiolabeled Platt cells were rinsed twice in PBS with divalent cations and resuspended in the same solution supplemented 
with 2 mg/ml BSA. The suspended ceils were treated with chondroitinase ABC or Flavobacterium  heparitanase as described in Laterra et al. (27) and in Materials 
and Methods; control cells were handled identically without the addition of any enzyme. Cells were then inoculated into plastic cluster dishes precoated with the 
indicated array of fibronectin fragments and/or PF4 at a total protein concentration of 20 rtg/ml; one set of wells contained 250 rtg/ml of peptide A (+ Pep A) 
while a second set of wells did not contain peptide A (-Pep A). After 1 h to allow cell attachment, unattached cells were rinsed out of the wells with PBS-containing 
divalent cations and the adherent cells assayed as described in Materials and Methods. The values presented are the percentages of the total number of cells inoculat- 
ed into wells divided into the number of cells adherent (x  100). Errors for multiple samples of each fragment are standard errors. 
The Journal of Cell Biology, Volume  106, 1988  936 Figure 7. Morphology and neurite outgrowth of Platt cells on various pFN or cFN fragments. Cluster dishes were coated with the following 
fibronectin fragments described in detail in Materials and Methods: (a) f29; (b) f38; (c) f44+47;  (d) fll0; (e) f145; (f) fl55. EGTA-detached 
Platt cells were inoculated into these cluster dishes and allowed to spread and generate neurites for 18 h. The wells were then fixed with 
glutaraldehyde and photographed under phase-contrast microscopy. Long narrow neurites are formed on fll0 and to a lesser extent on fl45 
and t"155 (broad arrowheads in d-f). Many short and broader extensions were more common on fl45 and fl55 (arrows in e and f). Under 
these same experimental conditions, intact pFN generated cells that were indistinguishable from those on f155 in f (data not shown). Bar, 
20 I.tm. 
the mixture of ill0 plus PF4 becomes sensitive to heparita- 
nase (by Student's t-test, P  <  0.0005  for row 5,  columns  1 
vs. 5) but not to peptide A, demonstrating the dominance in 
this situation of the tetravalent heparan sulfate-binding activ- 
ity  of  PF4  when  acting  as  a  supplement  to  the  RGDS- 
dependent  cell-binding  activity.  While  f145 displays  little 
sensitivity to prior chondroitinase treatment of cells (row 6, 
columns 3 and 4),  fl55 does display some (row 7, columns 
3 and 4);  in contrast, both f145 and fl55 display sensitivity 
to prior heparitanase treatment (row 5,  columns  1 vs. 5,  P 
<  0.005; row 7, columns  1 vs. 5, P  <  0.025).  Moreover, the 
enzyme treatment generates a resistance to peptide A not ob- 
served in the untreated control. This result suggests that cell 
surface heparan sulfate proteoglycan binding to the substra- 
tum ligand (specifically f155) increases the specific activity 
of the RGDS-dependent cell-binding domain. 
Neurite Outgrowth on Fibronectin Fragments 
On an appropriate substratum provided by more than one 
"cell-binding" activity of human pFN but not by its heparan 
sulfate-binding activity, Platt and La-N1 cells will generate 
neurites that have been characterized and quantitated previ- 
ously using the intact pFN molecule (12, 31, 46, 48). There- 
fore, fragments were tested for their ability to permit this 
"differentiation"  response.  As  shown  in  Fig.  7,  a-c,  the 
heparin-binding domain alone, as represented in the f29 or 
f38 fragments ofpFN or the f44+47 fragments ofcFN, were 
incompetent for neurite generation as expected from previ- 
ous  studies  (46);  cells  only  extended  pseudopodial-like 
processes on these substrata without any evidence of a neu- 
rite fiber. In contrast, Platt cells on ill0 were able to generate 
neurites (broad arrowheads in Fig. 7 d) and only 40% of this 
activity was sensitive to peptide A but not to peptide B (Table 
II, row 1, columns 1 vs. 2 with a Student's t-test, P <  0.005; 
also, see Fig. 8, a and b). Varying the concentration of pep- 
tide A  in this assay demonstrated that neurites on fll0 were 
resistant as high as 1,250 ~tg/ml (data not shown). Although 
f145 and fl55 could also generate two morphologically differ- 
ent neurites (broad arrowheads and arrows in Fig. 7, e and 
f; rows 2 and 3 in Table II) in a  reduced percentage of the 
cells, all of these processes were completely sensitive to pep- 
tide A  (Fig.  8, c  and d) with Student's t-test values of P  < 
0.0005; this stands in contrast to the complete inhibition of 
BALB/c  3T3  attachment on these  fragments at concentra- 
tions of peptide A below 100 Ixg/ml. Varying the concentra- 
tion of peptide A  in this assay revealed their sensitivity as 
low as  50  Ixg/ml  (data  not  shown).  These results  indicate 
that addition of the COOH-terminal heparin-binding domain 
to the molecule (a) reduces the percentage of cells competent 
for making neurites and (b) makes those cells that do gener- 
ate them completely sensitive to the RGDS peptide. Identical 
results were obtained with La-N1  cells. 
Dose responses of individual fragments for neurite forma- 
tion in Platt cells are shown in Table III. Even at 2  lxg/ml, 
intact pFN remains competent for inducing  neurites while 
f155 or fll0 do not (P < 0.0005). However, significant attach- 
ment activity still occurs on fl55 or fll0 at this concentration. 
Of note is the difference (P < 0.005) at 10 lag/ml between fl55 
and  fll0  in  specific  activities  for  neurite  formation.  This 
might  reflect  the  differing  contributions  of  the  RGDS- 
dependent versus RGDS-independent cell-binding domains 
in  the two fragments or,  alternatively, different conforma- 
tions of the two fragments on the substratum leading to very 
different affinities for the RGDS-dependent receptor. 
Combinations of fragments were then tested for neurite 
Mugnai et al. Adhesion and Fibronectin Sequences  937 Figure 8. Sensitivity  of neurite  outgrowth on various  fibronectin  fragments  to peptide A. EGTA-detached Platt cells were inoculated  into 
plastic  wells coated with the following fragments:  (a and b) ill0; (c and d) f155; (e and f) a mixture of 20 ~tg/ml each of fll0 plus  f38; 
(g and h) a mixture of 20 I.tg/ml each of fll0 plus f44+47. Peptide  A (250  ~tg/ml) was also added at the same time as cells  in b, d, f, 
and h. The cells were allowed to attach and spread for 18 h at 37~  At this peptide A concentration, neurites on intact pFN were completely 
resistant  (data  not shown).  The attached  cells  were then fixed and photographed. Bar, 20 Ixm. 
generation.  When equal amounts of f29 or f38 were mixed 
with  ill0  before  adsorbing  the  mixture  to the  substratum, 
some diminution of neurite outgrowth was observed, as well 
as some increase in the sensitivity to peptide A (Fig. 8, e and 
3~ Table II, rows 4  and 5).  In contrast,  addition of the EDa 
sequences of cFN via f44 +47 did result in complete sensitiv- 
ity to peptide A (Fig. 8, g and h and row 6 of Table II). These 
results demonstrate that (a) the intact f145 and f155 fragments 
become modulated by these additional  heparin-binding  se- 
quences far more effectively than mixtures of separate poly- 
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Soluble Peptide 
None  A  B 
Fragment  1  2  3 
1  fll0  20.0  +  1.3  (8)  11.8  _+  0.5  (4)  16.6  +  0.7  (4) 
2  f145  9.9  +  1.3  (8)  0  11.0  +  0.6  (4) 
3  f155  13.2  +  1.3  (8)  0  10.8  +  1.4  (4) 
4  fl10+f29  16.6  +  1.7  (8)  4.5  +  0.7  (4)  14.8  +  0.8  (4) 
5  fl10+f38  14.8  +  0.4  (8)  6.2  +  2.1  (4)  13.4  +  1.1  (4) 
6  fl10+f44+47  15.3  +  1.6  (4)  0  13.1  +  0.6  (4) 
*  EGTA-detached Platt cells were inoculated into plastic cluster dishes precoated with indicated fibronectin fragment (total protein concentration  of 20 I~g/ml). 
250 I~g/ml of peptide A or B were added to the medium and the cells were allowed to attach for 18 h. They were then fixed with glutaraldehyde and scored for 
neurites. The values presented are the percentages of neurite-bearing cells divided by the total number of cells in the microscope field. When intact pFN is tested 
for comparison (data not shown), results virtually identical with fl 10 were observed. Standard errors and the numbers of observations (in parentheses) are included. 
peptides and (b) the EDa sequences from cFN can modulate 
RGDS dependence more effectively than the pFN-derived 
sequences in f29 or f38. The same results were obtained for 
La-N1 cells. 
These experiments led to one in which fll0 was premixed 
with a varying concentration of f38 to determine the dose re- 
sponse (i.e., for f38) upon neurite generation mediated by 
ill0 and peptide A  sensitivity of this process.  ELISA data 
using  antibodies  directed toward each of these  fragments 
have shown that either one of the fragments does not com- 
petitively displace the other fragment in binding to the sub- 
stratum  (Lewandowska,  K.,  and  L.  A.  Culp,  manuscript 
submitted for publication), thereby verifying a true mixture 
of the two fragments on the substratum available to cell sur- 
face receptors. As shown in Table IV, neurite formation de- 
creased significantly (P < 0.025) at a 1:1 weight ratio of fll0 
and f38, and this was accompanied by increased peptide A 
sensitivity (ratio of +peptide/-peptide changing from 0.49 
to 0.25). At a weight ratio of 1:3 (fl10/f38), neurite formation 
was one-third the maximal level and there was complete sen- 
sitivity to peptide A. Therefore, only higher concentrations 
of f38 reduce the ability of ill0 to induce neurites and as- 
sociated with this reduction in the fraction of cells making 
Table III. Dose Dependence of  Neurite Outgrowth 
on Fragments* 
Fragment  Concentration  Neurite-bearing cells 
I~g/ml  % of total cell count •  SE 
pFN  50  25.1  ___  3.5  (204) 
10  17.2  +  2.1  (239) 
2  21.0  ___  1.1  (206) 
f155  50  26.9  +  3.9  (203) 
10  18.3  +  2.0  (202) 
2  3.0  +  0.9  (213) 
fll0  50  18.0  +  3.3  (249) 
10  2.7  +  0.3  (256) 
2  0  (126) 
* 48 well tissue culture dishes were coated with intact pFN, f155, or f110 at 
2, 10, and 50 ~g/ml for 1 h. After postadsorption of all wells with 250 I.tg/ml 
BSA, Platt cells detached with EGTA and rinsed twice with attachment medi- 
um were inoculated at 25,000 cells per well. The cells were allowed to spread 
and  make neurites  for  18  h;  they  were  then  fixed with glutaraldehyde  and 
scored  for neurites.  The numbers  represent  percent  of neurite-bearing  cells 
divided by total number of cells counted (given in parentheses).  Six indepen- 
dent fields were examined in each case and standard errors are included. 
Table IV. Peptide A Sensitivity of  Neurite Outgrowth on 
Fragment 110 Supplemented with Fragment 38* 
Fragment  Conc.  Neurite-bearing  cells 
FII0  F38  -Pep A  +Pep A  Ratio  +/- 
lag/ml  % +_  SE 
40  0  17.6  +  1.1  8.6  +  3.6  0.49 
30  10  16.6  _+  1.1  10.4  +  1.0  0.63 
20  20  10.7  +  1.4  2.7  +  0.5  0.25 
10  30  5.3  +  0.6  0.6  ___  0.4  0.11 
0  40  0.9  +  0.4  0  0 
* 48 well tissue culture dishes were coated with f110 mixed at varying ratios 
with t38 with total protein concentration kept constant at 40 I.tg/ml. The wells 
were then rinsed and postadsorbed with attachment medium. EGTA-detached 
Platt cells,  rinsed twice with attachment medium,  were inoculated into wells 
with half of the wells supplemented with 250 I.tg/ml  peptide A. After 18-h incu- 
bation cells were fixed with glutaraldehyde and scored for neurites as described 
in Materials and Methods. Percent of neurite-bearing cells per total number of 
cells is given along with standard errors based on six determinations  in each 
case. A ratio of values obtained in the presence of peptide A divided by values 
without peptide A in the medium is also included.  For comparison,  f155 ad- 
sorbed at 20 or 40 I.tg/ml generated  19.0% neurite-bearing cells without pep- 
tide A and <1%  with peptide A present  in the medium. 
neurites is increased sensitivity to peptide A inhibition. This 
result contrasts with the complete inhibition of neurite for- 
mation of f155 alone on the substratum by peptide A at all 
concentrations of fl55. 
Peptide A was shown previously to "reverse" neurite for- 
mation (48),  i.e., addition of peptide A  to Platt or La-N1 
cells that had already formed neurites on a chymotrypsin- 
generated  120K  cell-binding fragment of pFN resulted in 
their complete dissolution within hours.  A  similar experi- 
ment was used here to test for the dynamics of neurite out- 
growth based on the  premise that continuously migrating 
neurites,  mediated  only  by  the  RGDS-dependent  cell- 
binding domain, would be sensitive to inhibition with pep- 
tide A whereas static,  nonmoving neurites (or ones formed 
by an RGDS-independent mechanism) would be resistant to 
peptide A. A 24-h exposure to peptide A after 29 % of Platt 
cells had formed neurites on fll0 resulted in dissolution of 
two-thirds of these processes (Table V) with a P  <  0.0005. 
This occurred at a concentration of peptide A of 250 lxg/ml, 
which was shown before to completely reverse formation on 
the RGDS-dependent 120K chymotrypsin cell-binding frag- 
ment (48); doubling the peptide A concentration resulted in 
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Peptide A* 
Soluble peptide 
Fragment  None  A 
f110  28.6  +  2.9  10.5  ___  0.7 
f145  8.4  +  0.9  0 
f155  13.0  +  2.2  0 
f110+f29  11.0  +  0.6  6.8  +  0.2 
fl10+f38  13.5  +  2.2  6.0  +  0.4 
* EGTA-detached  Platt  cells were  inoculated  into  cluster dishes  precoated 
with the indicated fibronectin fragment (20 Ixg/ml) and allowed to attach for 
18 h. Peptide A at 250 ~tg/ml was then added to the medium and the incubation 
continued for an additional 24 h. The cells were then fixed and scored for neu- 
rites. When intact pFN was tested in the same protocol (data not shown), the 
same percentage of neurites were observed as on f110 and >70% of these neu- 
rites were resistant to 250 I.tg/ml peptide A. Values presented are the percen- 
tage (mean ___ SE of four observations) of neurite-bearing cells divided by total 
cell number in the field. 
only a  slightly smaller neurite-containing fraction of cells 
(data not shown). In contrast, neurite formation on fl45 and 
fl55 was completely sensitive to reversal and mixtures of ill0 
and f29 or f38 continued to show the partial sensitivity of fll0 
alone (Table  V).  Therefore, addition of a heparin-binding 
domain covalently linked,  as represented in fl45  or f155, 
generated much greater sensitivity to peptide A, presumably 
by increasing the "specific activity" of the RGDS-dependent 
cell-binding activity; simple addition of separate fragments 
f38 or f29 to ill0 could not reconstitute this activity. 
Discussion 
The human neuroblastoma cells used here provide an ideal 
biological system for evaluating the functional activities of 
the fibronectin fragments. They attach and spread by pseu- 
dopodial extension on heparan sulfate-binding substrata, in- 
cluding PF4  as  observed  previously (46)  and fibronectin 
fragments f29, f38, and f44+47 as observed in these studies. 
In contrast, they extend neurites that can be readily quan- 
titated in the population when reacting with one or more 
cell-binding regions of the fibronectin molecule (46, 48). It 
appears from the studies reported here that the second cell- 
binding activity of pFN  (RGDS-independent) reported by 
Waite et al. (48) as contributing to neurite outgrowth can be 
found in the sequences of thermolysin-generated fragment 
fll0 that are not found in chymotrypsin-generated fragment 
f120, the CellH domain depicted in Fig.  1, although its pre- 
cise location is still arbitrary and may be due to distant se- 
quences brought together by conformational folding. Adher- 
ence on fll0 is completely resistant to peptide A  and this 
resistance cannot be reduced by chondroitinase or hepari- 
tinase pretreatments of the cells,  indicating that a  cryptic 
GAG-binding domain close to the RGDS cell-binding do- 
main (28) is not responsible. Similarly, neurite outgrowth on 
ill0 is only partially sensitive to peptide A. Waite et al. (48) 
observed that both attachment and neurite outgrowth on a 
chymotrypsin-generated  cell-binding fragment of pFN (120K) 
were completely sensitive to peptide A. This second activity 
is not due to ganglioside binding since supplementation of 
cells with GTlb, known to bind to the fibronectins (24, 45, 
50, 51) and to effect human neuroblastoma adhesion on the 
appropriate  substratum  as  reported  previously  (31, 48), 
failed to alter responses of these cells (data not shown). 
Moreover,  these  studies  suggest  that  neighboring  se- 
quences in some of these fragments alter fragment conforma- 
tion on the  substratum,  thereby generating very different 
affinities for the 140K integrin receptor on the cell surface 
as well as a  second "receptor  y This would be reflected in 
differing sensitivities to the soluble RGDS  peptide in the 
former case, and there is clearly some evidence for this (e.g., 
the different sensitivities of neurite formation on fl45 or fl55 
to peptide A). In fact, all of the data reported here suggest 
that the RGDS-independent cell-binding activity is very sen- 
sitive to the conformation of fragments on the substratum, 
suggesting that this activity is not simple primary sequence 
in the polypeptide chain but results from two distant regions 
of sequence folding into proximity. Therefore, further cleav- 
age of ill0 into smaller fragments and assay of RGDS-inde- 
pendent neurite promotion may or may not permit refined 
mapping of this activity. 
A  second nonganglioside or nonproteoglycan cell-bind- 
ing activity has also been implicated in fibroblast adhesion 
studies with fibronectin by indirect evidence (6,  32,  47). 
Also, Humphries et al. (20) have directly mapped a second 
RGDS-independent cell-binding domain to the alternately 
spliced IIICS region of the fibronectins. This activity is cell- 
type specific for melanoma, is not effective for baby hamster 
kidney cells, and is dependent upon an REDV  sequence in 
the IIICS region.  A  second cell-binding activity reported 
here for human neuroblastoma cells maps differently from 
the REDV domain; it is contained within fll0 which has no 
IIICS sequence (none of the fragments used in these studies 
contains an entire IIICS region with the REDV  sequence 
[33]). Therefore, there may be three cell-binding domains in 
the  fibronectin  molecule,  only  one  of which  is  RGDS- 
specific and two of which may be cell-type specific. Further 
measurement of the dependence of adhesive responses of 
multiple cell types to these three binding domains should 
provide insight into the functional roles of three different 
"receptor" molecules in cells of developing embryos and in 
malignant cells during tumor progression. 
The complexity of neuroblastoma interactions with the 
fibronectins reported  here  shares  some findings with the 
results of McCarthy et al. (30) studying adherence and mi- 
gration of  melanoma cells on proteolytic fragments of  human 
pFN.  While  a  trypsin-generated 75K  fragment mediated 
both attachment and motility of melanoma cells,  a  much 
smaller pepsin-generated ll.5K fragment facilitated RGDS- 
dependent attachment but not motility. This suggested a sec- 
ond cell-binding domain in sequences not contained within 
the ll.5K fragment but contained within the 75K fragment 
responsible for migration. The results of neurite outgrowth 
on fll0 reported here are  remarkably consistent with the 
melanoma studies of McCarthy et al.  (30).  Furthermore, 
testing of the  ll.5K pepsin fragment in the neuroblastoma 
system also failed to detect significant neurite outgrowth, a 
motility function on the substratum for a specialized region 
of the cell surface, while attachment on this fragment was 
completely RGDS sensitive (data not shown). Therefore, two 
tumor cell types of neuroectodermal origin, melanoma and 
neuroblastoma, may share multiple mechanisms of attach- 
ment and migration, with migration in the latter case being 
reflected in neurite outgrowth. 
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Sequence differences  Adhesive response changes 
(A) Additional type III homology unit in 
f155 and I38; partial IIICS sequences in 
f145 and f29 
(B) ED~ sequences in f44+47 
(C) COOH-terminal heparin-binding 
domain 
(AI) Much better attachment on 138 than f29 
(A2) Attachment on f155 much more sensitive to peptide A 
(A3) Only covalently attached sequences effective 
(A4) Differences in neurite outgrowth on f145 or f155 
(A5) Differential sensitivity to peptide A  or enzymes on f145 or 
f155 
(BI) Intermediate attachment responses between f29 and 138 
(B2) Mixing of f44+47 with f110 increased peptide A  sensitivity of 
neurite formation (f29 or 138 did not) 
(CI) Better attachment on fl I0 than f145 or f155 
(C2) Greater resistance to peptide A  of attachment on f110 
(C3) More neurites formed on f110 and their partial resistance to 
peptide A  (complete sensitivity of neurites to peptide A  on 
f145 or fl55) 
(C4) Heparitanase treatment leads to resistance of attachment on 
f155 to peptide A 
These experiments have also revealed the significance of 
protein sequences neighboring known binding domains (par- 
ticularly the extra type III homology unit) in the adhesive re- 
sponses of human neuroblastoma cells. They also suggest, 
but certainly do not prove, that sequences generated by alter- 
native splicing ofpre-messenger RNAs may modulate neigh- 
boring binding domains (21, 25, 34, 41). The IIICS region 
can appear in multiple forms in cFN but in only two permu- 
tations in pFN (either with or without IIICS in the ~t- or 
13-chains, respectively). Zardi and his collaborators (8,  10) 
took advantage of the simplicity of the latter system by isolat- 
ing two complementary sets of fragments that differ in an ad- 
ditional type III homology unit from the ct- and 13-chains of 
human pFN, i.e., t29 vs. t38 and f145 vs. fl55 as displayed 
in Fig.  1.  F145 and 129 contain five amino acids from the 
COOH terminus of the IIICS region as well (33). In all ex- 
periments reported here,  there are  statistically  significant 
differences in responses to the complementary fragments as 
summarized in Table VI.  First,  cells adhered much more 
effectively to f38 than f29.  Second,  attachment to f155 is 
much more sensitive to peptide A than attachment to fl45; 
since both fragments contain the COOH-terminal heparin- 
binding domain, this difference must be due to partial IIICS 
sequences of fl45 or the additional type III homology unit 
of f155. Therefore, these sequences can modulate the biologi- 
cal "specific activity" of the RGDS-dependent cell-binding 
activity. Third, only covalently linked sequences can modu- 
late this attachment activity, which cannot be reconstituted 
by mixing of ill0 with 138 or 129. And,  fourth, there are 
significant differences in neurite extension and sensitivity to 
this differentiation process by peptide A addition or by pre- 
treatment of cells with GAG lyase (particularly heparitanase). 
Since the specific activities of these fragments are compara- 
ble and differences persist with fragments in the medium, it 
is unlikely that these differences result from differential bind- 
ing stability on the substratum, and this is supported by the 
ELISA data of Fig.  3. 
One mechanism for the effects of the differing type III ho- 
mology and IIICS sequences would be to affect the confor- 
mation of fragments bound to artificial glass or plastic sub- 
strata.  This conclusion is supported by the requirement of 
covalently linked domains in modulation. That a conforma- 
tional change can affect adhesion responses has been shown 
recently with human skin fibroblasts adhering and spreading 
more effectively on intact fibronectin that lacks asparagine- 
linked  oligosaccharides  when  compared  with  fibronectin 
that is glycosylated (22). Substratum-induced conformation 
changes would be expected to influence the affinity between 
the binding domain on the substratum and the cell surface 
receptor (32), as well as to affect accessibility of more than one 
cell surface ligand which would have a "cis" orientation on 
the surface of the cell (i.e., the two "receptors" are either 
bound to each other or, alternatively, are sufficiently close 
to effect cooperative interactions  [31]).  Evidence for such 
cooperation is provided by two types of data in these studies. 
First, neurite formation on fl45 or f155 can be reversed with 
peptide  A  while  formation on fll0 can only be partially 
reversed, revealing differential dependence on a second cell- 
binding domain. Second, pretreatment of cells with hepari- 
tanase results in attachment responses that are resistant to 
peptide A on fl55, a result that contrasts with the marked sen- 
sitivity to peptide A of control cultures. There appears to be 
some form of cooperative interaction between the heparan 
sulfate proteoglycan on the surface of these cells (29,  47a) 
and the RGDS-dependent receptor for fibronectin. Whether 
such a modulation could be effected on a natural collagenous 
substratum by these differing sequences remains to be deter- 
mined. 
In a couple of instances, effects upon adhesive responses 
were noted by the fragments carrying the so-called ED~ re- 
gion of the cellular fibronectins as summarized in Table VI 
(21, 25, 43).  Attachment on f44+47 from cFN was inter- 
mediate between the very poor response to 129 and the good 
response to 138, both from pFN.  Since all three fragment 
classes contain the  same COOH-terminal heparin-binding 
domain, this difference of f44+47 with f29 or 138 must be 
due to the EDa region of the fragments. Furthermore, mix- 
ing of 138 with fll0 only affected the peptide A sensitivity of 
neurite outgrowth at high ratios of f38/fl10 and only as a con- 
sequence of diminished proportion of cells able to form neu- 
rites. This contrasted with the complete sensitivity of 1145 
and f155 to peptide A and with the mixing of f44+47 with 
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would infer that EDa sequences can also affect the RGDS- 
dependent cell-binding activity of the molecule, at least as 
far as  fragment-mediated  responses are concerned.  Other 
experimental approaches, for example, using molecular bio- 
logically cloned individual and intact  fibronectin polypep- 
tides, will be required to determine whether EDa modulates 
binding reactions of the intact chains (42). 
The third category of modulation of cell-binding activities 
in these fragments derives from the contribution of the COOH- 
terminal heparin-binding  domain (Table VI). In virtually all 
cases the responses to ill0 were quite different from those on 
f145 or fl55, the latter two sharing the same heparin-binding 
domain sequences. These include better attachment efficiency 
on fll0, greater resistance of attachment to peptide A on fll0, 
and many  more neurite  processes on ill0 and their greater 
resistance to peptide A  (either by co-addition of peptide A 
with cells or by testing reversal of neurite formation). Hepa- 
ritanase pretreatment of cells makes cells resistant to peptide 
A  on f155, implicating the binding of cell surface heparan 
sulfate proteoglycan to the substratum  ligand as a regulator 
of the "specific activity" of the RGDS-dependent cell-binding 
activity.  This conclusion is also supported  by the complete 
sensitivity of neurite formation to peptide A on both fl45 and 
f155 but not on fll0. The biochemistry of heparan sulfate pro- 
teoglycans  has been  investigated  in a preliminary way  for 
EGTA-detached  Platt  cells (29)  and more recently  for the 
adhesion  sites  left bound  to  the  substratum  by  EGTA-de- 
tached Platt cells (47a).  This latter study demonstrated that 
90%  of the glycosaminoglycan in adhesion sites is retained 
in high molecular weight heparan sulfate proteoglycans and 
that non-proteoglycan proteins in Platt adhesion sites can al- 
ter the binding of these proteoglycans selectively to fibronec- 
tion but not to PF4 affinity  matrices. 
All of these results  taken together reveal  a complex and 
finely tuned set of regulators  that influence the responses of 
cells on the multifaceted fibronectins. Even though the fibro- 
nectins retain their principal extracellular matrix binding do- 
mains,  as  well as  the  RGDS-dependent  and  -independent 
cell-binding  domains,  as  a consequence of these multiple 
splicing events (21, 41),  neighboring protein sequences and 
possibly alternately spliced sequences can affect the adhesive 
responses of these neural  tumor cells in significant ways. 
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Note Added in Proof'. Rogers et al. (Rogers, S. L., P. C. Letourneau, B. A. 
Peterson,  L.  T.  Furcht,  and  J.  B.  McCarthy.  1987.  J.  Cell  Biol. 
105:1435-1442) have recently reported that chick peripheral nervous system 
neurons  can  attach  and  extend  neurites  on  either  RGDS-containing  or 
heparin-binding fragments of the FNs while central nervous system neurons 
preferentially interact  with heparin-binding  fragments.  These data provide 
additional evidence for multiple and alternative mechanisms for neuron sub- 
populations  to react with differing  domains in the FNs. 
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